Establishes "Period Equity and Menstrual Disorders Study Committee" in DOH.
The bill recognizes that period inequity manifests through high costs for menstrual products, lack of education on menstrual health, and insufficient access to necessary health care. The committee will delve into current policies related to the pricing and taxation of feminine hygiene products and aims to develop recommendations to improve affordability and accessibility. The effort to make these products more available is particularly crucial given that twenty-seven states currently impose a luxury tax on menstrual products, a necessity for many. The committee's initiatives could lead to significant changes in state law regarding the regulation and pricing of these essential items, promoting equity in reproductive health care.
A5023 establishes the 'Period Equity and Menstrual Disorders Study Committee' within the Department of Health to address period inequity, access to feminine hygiene products, and menstrual disorders affecting individuals who menstruate. This 15-member committee is tasked with studying the impacts of socioeconomic status, racial and gender disparities, and the stigma surrounding menstruation on the health and wellbeing of affected populations, particularly marginalized groups such as minorities, persons with disabilities, and the transgendered and non-binary communities.
The inclusion of a diverse committee aimed at tackling such a sensitive topic reflects a recognition of the complexities associated with menstruation, including societal stigma and health implications of using feminine products. Nevertheless, opposition may arise around the implications of legislative actions on free markets or local control, as well as debates regarding funding and resources allocated to such programs. Ultimately, A5023 points to the legislative intent of addressing long-standing issues of period equity, which stakeholders believe must be prioritized to improve the health outcomes of those who menstruate throughout New Jersey.